13 aprile 2021 | 10.01 LETTURA: 6 minuti
Company to launch Hemanext ONE® RBC Processing and Storage System in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years
Product now available in Norway, Blood centers in Italy, Switzerland, and France expected to complete validations later this year
LEXINGTON, Mass., April 13, 2021 /PRNewswire/ Hemanext Inc., a privately held medical technology company, today announced it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the innovative medical device to be sold in European markets. Blood center validations required for the adoption of the Hemanext ONE RBC Processing and Storage System were completed in Norway in 2020. The company expects blood centers in Italy, Switzerland, and France to complete validations in 2021. Hemanext plans to secure additional validations
Hemanext® Inc Receives CE Mark Certification for Innovative Red Blood Cell RBC Processing & Storage System
zazoom.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zazoom.it Daily Mail and Mail on Sunday newspapers.
Sickle Cell Disease Association of America, Inc Launches New Educational Materials to Support Children s Blood Transfusion
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.